Kidney Week

Clinical Practice Session

ANCA-Associated Vasculitis: Evidence and Uncertainties in Assessment and Management

October 24, 2024 | 04:30 PM - 06:00 PM

Location: Room 6A, Convention Center

Session Description

Assessment and management of ANCA-associated vasculitis (AAV) have improved in recent years. However, despite substantial evidence, not only do significant uncertainties exist, but more targeted and less toxic therapies are still needed. This session presents recent advances, outlines evidence and uncertainties, and examines unmet needs and future opportunities in AAV, focusing on the kidneys as a commonly affected end organ.

Support is provided by an educational grant from Travere Therapeutics, Inc.

Learning Objective(s)

• Discuss newer assessment tools for kidney risk in ANCA-associated glomerulonephritis
• Develop a rational approach to acute management of AAV, while appreciating the uncertainties that exist
• Describe current imprecision in the clinical and laboratory assessment of AAV disease activity, remission, and relapse
• Identify new opportunities for improving the assessment and management of AAV

Learning Pathway(s)

• Glomerular Diseases

Moderators

• Koyal Jain, MD, MPH, FASN
• Anushya Jeyabalan, MD

Presentations

• Predictive Tools and Prognostic Indicators in ANCA-Associated Glomerulonephritis
  04:30 PM - 04:50 PM
  
  • Silke R. Brix, MD

Predictive Tools and Prognostic Indicators in ANCA-Associated Glomerulonephritis

October 24, 2024 | 04:30 PM - 04:50 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Pitfalls in Diagnosis of ANCA-Associated Vasculitis
  04:50 PM - 05:10 PM
  
  • Ingeborg M. Bajema, MD, PhD

Pitfalls in Diagnosis of ANCA-Associated Vasculitis

October 24, 2024 | 04:50 PM - 05:10 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• New Therapeutic Targets and Therapies for ANCA-Associated Glomerulonephritis
  05:10 PM - 05:30 PM
  
  • A. Richard Kitching, MBChB, PhD, FASN

New Therapeutic Targets and Therapies for ANCA-Associated Glomerulonephritis

October 24, 2024 | 05:10 PM - 05:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Indicators of Remission and Relapse in ANCA-Associated Vasculitis: Where Are We and What Are the Challenges?
  05:30 PM - 05:50 PM
  
  • Mark Alan Little, MBChB, PhD

Indicators of Remission and Relapse in ANCA-Associated Vasculitis: Where Are We and What Are the Challenges?

October 24, 2024 | 05:30 PM - 05:50 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Q&A
  05:50 PM - 06:00 PM
  

Q&A

October 24, 2024 | 05:50 PM - 06:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.